THE COOPER COMPANIES, INC. Funds and ETFs The Cooper Companies, Inc.
Equities
COO
US2166485019
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 96.76 USD | -0.46% |
|
+0.83% | +2.27% |
| 04-03 | Citigroup Raises Price Target on Cooper Companies to $116 From $108, Keeps Buy Rating | MT |
| 03-21 | Cooper Companies Insider Sold Shares Worth $5,521,230, According to a Recent SEC Filing | MT |
ETFs positioned on The Cooper Companies, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.05% | 121 M€ | +8.66% | - | |
| 0.05% | 2,517 M€ | +13.47% | - | |
| 0.05% | 34 M€ | +12.87% | - | |
| 0.04% | 786 M€ | -.--% | ||
| 0.04% | 23 M€ | -.--% | - | |
| 0.04% | 1 M€ | -.--% | ||
| 0.04% | 14 M€ | +16.19% | - | |
| 0.04% | 57 M€ | +22.79% | - | |
| 0.04% | 273 M€ | -.--% | ||
| 0.04% | 655 M€ | -.--% | - | |
| 0.04% | 1,174 M€ | +23.54% | ||
| 0.04% | 0 M€ | 0.00% | - | |
| 0.04% | 206 M€ | -.--% | ||
| 0.04% | 284 M€ | -.--% | ||
| 0.03% | 205 M€ | -.--% | ||
| 0.03% | 283 M€ | +21.63% | ||
| 0.03% | 607 M€ | +0.05% | - | |
| 0.03% | 1,166 M€ | +0.26% | - | |
| 0.02% | 391 M€ | +9.24% | - | |
| 0.02% | 571 M€ | +8.81% | - | |
| 0.02% | 34 M€ | +9.50% | - | |
| 0.02% | 306 M€ | +6.36% | - | |
| 0.02% | 39 M€ | +6.45% | - | |
| 0.01% | 17 M€ | +5.38% | - |
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVisionâs products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and womenâs health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within womenâs health. CooperSurgicalâs brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Calendar
30/05/2024
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
96.76
USD
Average target price
107.9
USD
Spread / Average Target
+11.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.27% | 19.23B | |
| +15.25% | 103B | |
| -15.77% | 2.36B | |
| +19.86% | 2.01B | |
| +28.88% | 1.23B | |
| -35.02% | 755M | |
| -5.96% | 683M | |
| -45.04% | 666M | |
| +24.65% | 501M | |
| +26.77% | 479M |
- Stock Market
- Equities
- COO Stock
- Funds and ETFs The Cooper Companies, Inc.
